Siim Land: The Next Cold War Is About Living to 150
Peer-Reviewed Research
Key Takeaways
- Monitor RAGE pathway research for future anti-aging potential, but don’t expect breakthroughs yet due to limited lifespan data.
- Prioritize proven longevity pathways like mTOR, IGF-1, and cellular senescence over RAGE inhibition for now.
- Watch human trials for partial reprogramming (OSK/Yamanaka factors), Klotho, and senolytic gene therapies as more promising near-term options.
- Be skeptical of unverified claims from authoritarian regimes about longevity breakthroughs without peer-reviewed data.
Notable Quotes
“Eating a healthy diet, exercising, and sleeping enough is not going to make you live to the age of 120 and 150. To make humans live to the age of 120, 30, and 50, we’re going to need something more dramatic, such as gene therapies.”
Bottom Line
Focus on established longevity practices while tracking legitimate gene therapy trials (like partial reprogramming and Klotho), but ignore unsubstantiated claims about extreme lifespan extension from unverified sources.
Explore More
- Siim Land’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network